Literature DB >> 10516415

Metformin and risk of cardiovascular disease.

R C Turner1, R R Holman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516415     DOI: 10.1159/000006910

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  5 in total

1.  Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women.

Authors:  Yanping Li; Yang Hu; Sylvia H Ley; Swapnil Rajpathak; Frank B Hu
Journal:  Diabetes Care       Date:  2014-08-22       Impact factor: 19.112

2.  Metformin and mortality.

Authors:  S S Lund
Journal:  Diabetologia       Date:  2013-02-02       Impact factor: 10.122

3.  Management of Diabetes with Coronary Artery Disease.

Authors:  Michelle Fischmann Magee; Adeyinka A Taiwo; Barbara Viventi Howard
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-02

Review 4.  Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Authors:  R J Stevens; R Ali; C R Bankhead; M A Bethel; B J Cairns; R P Camisasca; F L Crowe; A J Farmer; S Harrison; J A Hirst; P Home; S E Kahn; J H McLellan; R Perera; A Plüddemann; A Ramachandran; N W Roberts; P W Rose; A Schweizer; G Viberti; R R Holman
Journal:  Diabetologia       Date:  2012-08-10       Impact factor: 10.122

5.  Metformin and its clinical use: new insights for an old drug in clinical practice.

Authors:  Arrigo F G Cicero; Elisa Tartagni; Sibel Ertek
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.